NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/05/2025
Voltar para busca
Dado oficial do USPTO
FLINDR THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
FLINDR THERAPEUTICS
ST13
US500000098451969Classe
1, 5, 42
Pedido
98451969
Registro
7798473
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
20/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
15/03/2024
Data de registro
20/05/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/05/2025
Última transação
20/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Amsterdam, NL
Examinador
AIKENS, RONALD E
Unidade examinadora
M30
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Immagene B.V.
Representantes
Erica R. Halstead Womble Bond Dickinson (US) LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparationsbiologically compatible chemical substances for scientificlaboratoryclinical and medical research; biological tissuemammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientificlaboratoryclinical and medical research; therapeutic tissuetherapeutic tissue comprising or derived from stem cells or progenitor cellscompositions comprising or derived from the therapeutic tissues for scientificlaboratoryclinical and medical research
Classe 5
Pharmaceuticalsmedical and veterinary preparations for use in oncology; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceuticals for use in oncology
Classe 42
Pharmaceutical drug discovery and development services; scientific services and researchdevelopment and design relating thereto in the field of oncology; medical research; technological servicesresearch and design relating thereto in the fields of small molecule therapeutics; design and development of medical technology; design and development of medical diagnostic apparatus; consultancy services in the field of technological development of small molecule therapeutics; industrial analysis and industrial research services in the fields of small molecule therapeutics; design and development of computer hardware and software; design and development of small molecule therapeutics hardware; design and development of computer software for use with small molecule therapeutics hardware; clinical research in the fields of small molecule therapeutics; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodiesimmuno-oncologyinflammationhematology and infectious disease; Medical and scientific researchconducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; scientific screening and assaying of therapeutics for medical purposes; chemical analysis; chemical research; biotechnology research; consultancy relating to biotechnology; consultancy services relating to research and development in the field of therapeutics
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
20/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/04/2025
PUBO
PUBLISHED FOR OPPOSITION
01/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/03/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
10/03/2025
ALIE
ASSIGNED TO LIE
10/03/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/03/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
07/03/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/03/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/02/2025
GNSL
LETTER OF SUSPENSION E-MAILED
10/02/2025
CNSL
SUSPENSION LETTER WRITTEN
10/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/10/2024
GNRT
NON-FINAL ACTION E-MAILED
07/10/2024
CNRT
NON-FINAL ACTION WRITTEN
07/10/2024
DOCK
ASSIGNED TO EXAMINER
25/09/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2024
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
17/06/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
17/06/2024
NWAP
NEW APPLICATION ENTERED
17/03/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FLINDR THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.